HB421: AN ACT relating to colorectal cancer screenings.
Legislative Summary
Amend KRS 304.17A-257 to require coverage for all colorectal cancer examinations and laboratory tests specified in the United States Multi-Society Task Force on Colorectal Cancer guidelines for certain covered persons; require coverage for all United States Food and Drug Administration-approved bowel preparation prescribed in connection with a colorectal cancer examination or test; prohibit prior authorization requirements for colorectal cancer examinations and laboratory tests; provide an exemption from the cost sharing prohibition for Health Savings Account-qualified High Deductible Health Plans under certain circumstances; provide that the colorectal cancer examination and laboratory test coverage section applies to health benefit plans issued or renewed on or after January 1, 2026; establish construction of certain provisions for purposes of federal law and require state officials to comply; require the Cabinet for Health and Family Services or the Department for Medicaid Services to obtain federal approval, if necessary and comply with notice requirements; EFFECTIVE, in part, January 1, 2026.
Demographic Impact
Overall analysis of equity impact
Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
Amendments
House Committee Substitute
House Committee Substitute 1
House Committee Substitute
Health Mandate to House Committee Substitute 1
House Committee Substitute
Local Mandate to House Committee Substitute 1
Roll Call Votes
Status Information
Sponsors
Primary Sponsor
